Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oct 19, 2010

Premium

WaferGen said last week that Gary Schroth has joined the firm as senior vice president of genomics research and applications, a new position at the company.

Schroth most recently was Illumina's senior director of R&D, and he also held management jobs at Life Technologies' Applied Biosystems, Genelabs Technologies, and Gen-Probe.


Intrexon, a privately held synthetic biology company, this week appointed Grace Colón as president of its Industrial Products Division and a senior vice president.

Colón most recently was head of clinical operations for Gilead Sciences. Prior to Gilead, she was vice president of corporate planning at Affymetrix. Before that, Colón was a consultant with McKinsey & Co.

She holds a PhD in chemical engineering from the Massachusetts Institute of Technology and a BS degree in chemical engineering from the University of Pennsylvania.


Peter Lewis has been named vice president of finance and administration at BioScale, the firm said last week.

Lewis was most recently chief financial officer at First Boston Pharma. Prior to First Boston, he served as VP of finance and administration at Affymetrix. He also was CFO of Genetic Microsystems, and helped negotiate its merger with Affy.

Lewis holds a BS in mechanical and materials engineering and an MBA from the University of Connecticut.


Bionest Partners has appointed Sean Xinghua Hu as managing director, North America, and head of Bionest USA.

Hu previously served as a business development professional at Illumina, and was a senior R&D scientist and operations manager at CuraGen.

He holds a PhD in genomics from New York University, an MBA from the University of Pennsylvania, and a BS in chemistry from Peking University in China.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.